Investigations showed: haemoglobin 12 8 g/dl; white cell count 11 3 x 109!l (11 300/mm3), with 15 % eosinophils; blood urea 10-3 mmol/I (62 mg/ 100 ml); blood glucose 5-4 mmol/l (98 mg/100 ml); and serum sodium 129 mmol(mEq)/l, potassium 5-2 mmol(mEq)/l, and chloride 97 mmol (mEq)/l. Chest and abdominal x-ray pictures were normal. Antinuclear factor and thyroid and parietal cell antibodies were absent. The basal plasma cortisol concentration was low and there was no response to prolonged stimulation with tetracosactrin, which confirmed primary adrenocortical failure. Sweat was collected from his back and tested for electrolytes.
Two months after treatment with cortisone acetate and fludrocortisone the patient felt well and had gained weight. The We report here some findings that may be relevant for planning research on this subject.
Methods and results
Confluent cultures of BS-C-1 cells in Falcon plastic tissue culture flasks or glass tubes were infected with adenovirus 5, echovirus 6, and 7, herpes simplex virus type 1, or Semliki Forest virus in the presence or absence of 10 mg/ml disodium cromoglycate (Lomudal). Replication of the viruses was followed by daily microscopy of the cultures.
Cromoglycate prevented or delayed the appearance of typical cytopathic effects caused by the viruses. The protective effect was dose-dependent in two dimensions, being more pronounced at low multiplicities of infection and undetectable below 1 mg/ml of disodium cromoglycate. Results from a standard infectivity titration of four of the viruses in the presence of 10 mg/ml of disodium cromoglycate are shown in the table. No effect on uninfected cultures was visible in these experiments, but when BS-C-1 cells were passaged several times in the presence of 10 mg/ml of disodium cromoglycate the cells flattened and the rate of cell proliferation slowed down. These effects were fully reversible in 24 hours when the growth medium containing the drug was replaced by normal one.
The drug may not have any direct effect on the viruses, as pretreatment of echovirus 7 virus with 10 mg/ml disodium cromoglycate did not diminish its infectivity. Furthermore, one-step replication curve of Semliki Forest virus in BS-C-1 cells, as studied by plaque assay of virus infectivity, was not changed, despite complete inhibition of the concomitant cytopathic effects in the cultures. On the other hand, agglutination of goose erythrocytes by Semliki Forest virus was inhibited by cromoglycate at concentrations as low as 100 ,tg/ml. These results suggest that the inhibition of virus-induced cytopathic effects by disodium cromoglycate may be based on preventing the cytolytic effects of the viruses rather than on interfering with the replication of the viruses.
Effect of disodiunm cromoglycate on infectivity titration of some viruses in BS-C-1 cells* 
Comment
The concentrations of disodium cromoglycate required for this cytoprotective effect were about 1000 times those active in "stabilising" mast cell membranes.3 It would therefore be easy to ignore these observations as an unspecific effect completely irrelevant to the clinical action of the drug. Nevertheless, under 5"o of a given inhalation dose of DSCG will be absorbed from the lung, while most of the rest will be either trapped by the upper respiratory tract or transported back to the throat by the ciliary epithelium of respiratory tract, swallowed, and secreted in the faeces.5 Inhaling several doses of disodium cromoglycate daily, 20 mg each, could result in relatively high concentrations of the highly hydrophilic drug in the thin aquaeous film on the laryngopharyngeal mucosa. This might not protect these tissues from viral infections, but by preventing tissue destruction, high concentrations of cromoglycate could diminish local inflammation and thereby effectively alleviate the symptoms of the disease.
We thank Fisons Ltd, Loughborough, UK, for providing the disodium cromoglycate.
IBritish Medical3Journal, 1972, 2, 159. 
